Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials

Major depressive disorder (MDD) is characterized by increased rates of impaired function and disability. During antidepressant treatment, functional improvement often lags behind symptomatic resolution, and residual impairment is associated with an increased risk for relapse. When evaluating MDD tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sambunaris, Angelo, Gommoll, Carl, Chen, Changzheng, Greenberg, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047314/
https://www.ncbi.nlm.nih.gov/pubmed/24667487
http://dx.doi.org/10.1097/YIC.0000000000000033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047314/
https://www.ncbi.nlm.nih.gov/pubmed/24667487
http://dx.doi.org/10.1097/YIC.0000000000000033

Ejemplares similares